Does Highmark Cover ADHD Treatment in West Virginia? A 2026 Guide

Last updated: July 14, 2026

Looking for ADHD care that works with your Highmark plan? Klarity Health connects you with licensed providers who accept Highmark Blue Cross Blue Shield of West Virginia. See if you may qualify for ADHD treatment through Klarity.

Does Highmark Blue Cross Blue Shield Cover ADHD Treatment in West Virginia?

If you have Highmark Blue Cross Blue Shield of West Virginia coverage, ADHD diagnosis and treatment may be covered under your health plan — but the extent of coverage, cost-sharing, and medication access depends on your specific plan type, formulary tier, and prior authorization requirements. This guide walks through what Highmark Blue Cross Blue Shield West Virginia (Highmark BCBS WV) members may expect when seeking ADHD evaluation, medication management, and behavioral therapy through their plan in 2026.

Highmark West Virginia Inc. d/b/a Highmark Blue Cross Blue Shield is the Blue Cross Blue Shield licensee serving West Virginia. Prescription drug benefits for Highmark BCBS WV commercial members are managed through HM Health Solutions, a Highmark subsidiary that serves as the pharmacy benefits manager (PBM) for Highmark plans. HM Health Solutions administers the Highmark formulary, prior authorization programs, and specialty drug management — it is distinct from OptumRx, CVS/Caremark, Prime Therapeutics, or Express Scripts.

West Virginia Mental Health Parity Law and ADHD Coverage

West Virginia’s mental health parity statute, W. Va. Code § 33-25-8r et seq., requires fully insured commercial health benefit plans issued in the state to cover mental health and substance use disorder (MH/SUD) benefits on terms no more restrictive than medical and surgical benefits. ADHD is a recognized mental health condition, and parity protections apply to ADHD diagnostic evaluation, medication management, and behavioral therapy under Highmark BCBS WV commercial plans.

Key implications of WV parity for ADHD coverage include:

• Highmark may not impose higher deductibles, copays, or visit limits on ADHD services than it applies to comparable medical benefits
• Nonquantitative treatment limitations (NQTLs) — such as prior authorization requirements, step therapy, and fail-first protocols — must be applied consistently between ADHD/mental health services and analogous medical/surgical benefits
• Members whose ADHD prior authorization is denied may request a written explanation of the NQTL criteria applied, which is a federally protected right under MHPAEA

Important carve-out: Many West Virginia employers — particularly those in coal mining, natural gas (Marcellus Shale), chemical manufacturing, and heavy industry — sponsor large self-funded ERISA plans. These plans are governed by federal MHPAEA rather than W. Va. Code § 33-25-8r et seq., and the state statute does not apply. Members on self-funded employer plans should verify their federal MHPAEA rights separately. Contact Highmark at the number on your member ID card to confirm whether your plan is fully insured or self-funded.

ADHD Services Highmark BCBS WV May Cover

Under most Highmark BCBS WV commercial plans, covered ADHD-related services may include:

• Initial psychiatric or psychological evaluation and ADHD diagnostic assessment
• Prescription medication management (stimulants and non-stimulants)
• Individual behavioral therapy (cognitive behavioral therapy, behavioral modification)
• Parent training and behavior management coaching
• Telehealth-based ADHD evaluation and ongoing medication management
• Group therapy and skills training
• School-based and coordinated care referrals

Coverage specifics — including cost-sharing, deductible applicability, and referral requirements — vary by plan type. Review your Summary of Benefits and Coverage (SBC) or call Highmark at 1-800-544-7811 to confirm your specific benefits.

Highmark BCBS WV ADHD Medication Formulary (HM Health Solutions)

Prescription drug coverage for Highmark BCBS WV commercial members is administered through HM Health Solutions. The formulary organizes medications into tiers that determine your out-of-pocket cost. Lower-tier medications typically carry lower copays or coinsurance; higher-tier medications cost more and may require prior authorization or step therapy.

Based on Highmark’s published formulary updates and Non-Preferred CNS Stimulant Products policy, the following is a general guide to how common ADHD medications are typically covered under Highmark commercial plans. Always verify your specific plan’s formulary, as tier placement and coverage details may vary by plan year and individual plan design.

Formulary tiers are general estimates based on Highmark’s published Non-Preferred CNS Stimulant Products policy and formulary update documents. Tier placement varies by plan type (commercial employer, ACA individual/family, small group) and plan year. Always verify your specific formulary through Highmark’s member portal or by calling the pharmacy benefit number on your ID card.

Note on generic lisdexamfetamine: Generic lisdexamfetamine dimesylate (generic for Vyvanse) has been available since 2023. Highmark’s Non-Preferred CNS Stimulant Products policy lists generic lisdexamfetamine as a required step-therapy alternative before some branded products are covered. Verify tier placement and PA requirements with your specific plan before filling.

Electronic Prescribing of Controlled Substances (EPCS) in West Virginia

West Virginia’s controlled substance prescribing law, W. Va. Code § 60A-4-403a, imposes an electronic prescribing requirement that applies to all controlled substance schedules — not just Schedule II, as is the case in many other states. ADHD stimulant medications (amphetamine salts, methylphenidate, lisdexamfetamine, dextroamphetamine) are Schedule II controlled substances and are fully subject to EPCS requirements in West Virginia.

What this means for Highmark BCBS WV members seeking ADHD medication:

• Your prescriber must transmit Schedule II ADHD prescriptions electronically to the pharmacy — paper prescriptions for stimulants are generally not accepted in West Virginia (with limited statutory exceptions)
• Limited exceptions apply: documented technology failure, prescribing in a setting without electronic prescribing capability, prescribing during a declared emergency, prescribing in a correctional facility, or where the patient is receiving hospice or long-term care services
• Telehealth prescribers operating in or for WV patients must use EPCS-compliant platforms — verify your provider’s capability before your appointment
• EPCS compliance does not change your formulary tier or PA requirements — it governs the prescribing transmission method only

Additionally, under West Virginia Senate Bill 267 (2024), all prior authorization requests to Highmark BCBS WV must be submitted electronically through Availity, Highmark’s provider portal. Paper PA forms are no longer accepted in West Virginia. If you are a provider seeking PA for a patient’s ADHD medication, submissions go through Availity — not paper forms.

Prior Authorization for ADHD Medications Under Highmark BCBS WV

Highmark’s Non-Preferred CNS Stimulant Products policy requires prior authorization for branded and non-preferred stimulant formulations. Under this policy, Highmark typically looks for:

• A confirmed ADHD diagnosis (consistent with DSM-5 diagnostic criteria) appropriate for the patient’s age
• Documentation of medical necessity for the specific formulation requested
• Evidence of trial and failure of, or clinical contraindication to, one or more preferred generic stimulant alternatives (amphetamine/dextroamphetamine ER, methylphenidate ER, dexmethylphenidate ER) before a non-preferred branded stimulant is approved
• For brand Vyvanse specifically: prior failure of generic lisdexamfetamine dimesylate may be required in addition to other preferred generic alternatives
• For reauthorization: prescriber attestation of positive clinical response to therapy

PA decision timelines (typical):

• Standard: 2–3 business days
• Urgent/expedited: 24–72 hours when medical urgency is documented
• PA appeal (Level 1): 30–60 days for standard; 72 hours for expedited
• External independent review: available if internal appeal is denied

If your ADHD medication PA is denied, you have the right to file an internal appeal with Highmark and, if the internal appeal fails, to request an external independent review by a state-certified review organization. Under W. Va. Code § 33-25-8r et seq., Highmark cannot apply more restrictive PA criteria to mental health (ADHD) medications than it applies to comparable medical conditions.

Behavioral Therapy for ADHD Under Highmark BCBS WV

Behavioral and psychological treatments for ADHD are typically covered under Highmark BCBS WV plans alongside medication management. Commonly covered ADHD behavioral services may include:

• Cognitive behavioral therapy (CBT) targeting executive function, organization, and impulsivity
• Behavioral modification therapy, particularly for children
• Parent-child interaction therapy (PCIT) and parent behavioral management training
• Organizational skills coaching integrated into therapy
• Group therapy for social skills and peer interaction
• Telehealth behavioral therapy sessions — covered under most Highmark plans

Parity protections under W. Va. Code § 33-25-8r et seq. require that behavioral therapy visit limits, copay structures, and referral requirements for ADHD therapy not exceed the restrictions applied to comparable medical services.

How to Verify Your ADHD Coverage with Highmark BCBS WV

Before scheduling an ADHD evaluation or filling a prescription, consider taking these steps to understand your benefits:

1. Check your formulary: Log into Highmark’s member portal or use the formulary search at highmark.com to look up your specific ADHD medication, confirm its tier, and see whether PA is required
2. Call member services: Contact Highmark BCBS WV at 1-800-544-7811 to verify ADHD diagnostic, therapy, and medication benefits under your specific plan
3. Confirm network providers: Use Highmark’s provider directory to find in-network psychiatrists, nurse practitioners, and therapists with ADHD experience in West Virginia
4. Ask about telehealth: Confirm whether telehealth ADHD evaluation and prescribing is covered under your plan, and whether your provider’s telehealth platform is EPCS-compliant for WV prescriptions
5. If denied, appeal: PA denials and benefit denials have appeal rights — request a written denial with the clinical criteria used, and contact the WV Insurance Commissioner at 1-888-879-9842 if you need assistance with an external review

Getting ADHD Treatment Through Klarity Health

Klarity Health is a telehealth platform with a network of 2,000+ licensed providers — including psychiatrists, nurse practitioners, and therapists — who may be able to work with your Highmark BCBS WV plan. Klarity’s ADHD care model includes:

• Online ADHD evaluation with a licensed provider
• Medication management, including EPCS-compliant electronic prescribing for West Virginia patients
• Coordination for prior authorization documentation when needed for non-preferred stimulant formulations
• Ongoing telehealth follow-up and titration support

See if you may qualify for ADHD treatment through Klarity Health and check whether Klarity providers may accept your Highmark plan.

Contact Information

• Highmark Blue Cross Blue Shield West Virginia (member services): 1-800-544-7811
• Highmark provider portal (PA submissions): Availity at availity.com
• West Virginia Insurance Commissioner: 1-888-879-9842 | wvinsurance.gov
• SAMHSA National Helpline (mental health/substance use): 1-800-662-4357
• 988 Suicide and Crisis Lifeline: Call or text 988

Frequently Asked Questions

Does Highmark BCBS WV cover an ADHD evaluation?

Highmark BCBS WV may cover initial psychiatric or psychological evaluation for ADHD diagnosis under mental health benefits. Depending on your plan, cost-sharing — such as a specialist copay or coinsurance after your deductible — may apply. Telehealth evaluations are typically covered under most Highmark plans. Verify your specific evaluation benefits by calling 1-800-544-7811 or logging into your member portal.

Does Highmark cover generic Adderall (amphetamine salts) without prior authorization?

Generic amphetamine salts in immediate-release (IR) and extended-release (ER) formulations are typically listed as preferred medications on Highmark’s formulary (Tier 1–2) and often do not require prior authorization for in-network pharmacy claims. Brand-name Adderall and non-preferred branded stimulants are subject to the Non-Preferred CNS Stimulant Products policy, which requires PA and step therapy. Always verify with your specific plan formulary.

Why does my ADHD stimulant prescription require EPCS in West Virginia?

West Virginia’s EPCS law (W. Va. Code § 60A-4-403a) requires electronic transmission for all controlled substance prescriptions, including Schedule II stimulants used to treat ADHD. This applies statewide and to telehealth prescribers serving West Virginia patients. Your provider must use an EPCS-compliant electronic prescribing system to transmit your stimulant prescription directly to your pharmacy.

Does West Virginia’s parity law protect my ADHD coverage?

Yes — W. Va. Code § 33-25-8r et seq. applies to fully insured commercial plans and requires that ADHD (a mental health condition) be covered on parity with comparable medical/surgical benefits. However, if you are enrolled in a large self-funded employer plan (common among WV mining, chemical, or energy sector employees), federal MHPAEA applies rather than the state statute. Contact Highmark to confirm whether your plan is fully insured or self-funded.

What can I do if Highmark denies prior authorization for my ADHD medication?

If Highmark denies your ADHD medication PA, you have several options: (1) ask your provider to submit supporting clinical documentation for reconsideration; (2) file a formal internal appeal with Highmark — request the written denial with the specific clinical criteria applied; (3) request an expedited appeal if your condition is urgent; (4) if the internal appeal is denied, request an external independent review through the WV Insurance Commissioner’s office (1-888-879-9842). Under WV parity law, Highmark cannot apply more restrictive criteria to ADHD medications than to comparable medical conditions.

Disclaimer: This article is provided for informational purposes only and does not constitute insurance, medical, or legal advice. Insurance coverage for ADHD treatment varies significantly by plan, employer, and benefit year. The formulary information above is based on Highmark’s publicly available formulary update documents and is subject to change. Always verify your specific benefits by reviewing your plan documents or contacting Highmark Blue Cross Blue Shield of West Virginia at 1-800-544-7811. Coverage decisions are made by your insurance plan, not by Klarity Health. Use of “may,” “typically,” and “often” throughout reflects the inherent variability in insurance coverage.